HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical transplant trial offers hope for devastating new disease
Disease control Recruiting nowThis study is testing whether a stem cell transplant from a donor can control VEXAS syndrome, a serious and often treatment-resistant disease that causes severe inflammation and blood problems. Researchers will give 54 adults with severe VEXAS a transplant after using medications…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope to stop devastating transplant failure
Disease control Recruiting nowThis early study is testing whether a drug called emapalumab can prevent graft rejection in high-risk patients receiving stem cell transplants. Researchers believe blocking a specific immune signal (interferon gamma) might stop the body from rejecting the new cells. The trial wil…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for leukemia patients when cancer returns after transplant
Disease control Recruiting nowThis study tests whether the drug Inotuzumab can eliminate tiny amounts of returning cancer cells in patients with acute lymphoblastic leukemia (ALL) who have already undergone a stem cell transplant. The goal is to prevent a full cancer relapse and improve survival. Researchers …
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope to stop dangerous bleeding in transplant patients
Disease control Recruiting nowThis study is testing if a drug called etamsylate can prevent serious bleeding in patients who have low platelet counts after a stem cell transplant. About 404 adult patients will be randomly assigned to receive either etamsylate or a placebo (inactive substance) to see which is …
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Could a lower dose of a harsh transplant drug be the key to fewer complications?
Disease control Recruiting nowThis study aims to find the lowest effective dose of a drug called cyclophosphamide, given after a stem cell transplant, to prevent a serious complication called graft-versus-host disease (GVHD). The goal is to reduce the drug's own side effects while still protecting patients. I…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Ancient heat therapy trialed to shield transplant patients from agonizing complication
Prevention Recruiting nowThis study is testing whether adding moxibustion, a traditional Chinese heat therapy, to standard care can prevent a painful bladder condition called hemorrhagic cystitis in patients recovering from stem cell transplants. It will involve 266 patients who have received a donor ste…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Yi Zhang • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC
-
New hope to protect Kids' bones after Life-Saving transplants
Prevention Recruiting nowThis study is testing if giving a bone-strengthening medication called zoledronate early can safely prevent bone disease and fractures in children who have had a stem cell transplant. It focuses on children aged 5 to 18 who are at high risk for bone problems. The goal is to see i…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
New program aims to help cancer survivors get back to work
Symptom relief Recruiting nowThis study is testing a new support program designed to help people who have had a stem cell transplant return to work. It will enroll about 35 participants who are worried about job challenges in the six months after their transplant. The goal is to see if the program is practic…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: MGH Institute of Health Professions • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Virtual companion aims to ease cancer transplant anxiety
Symptom relief Recruiting nowThis study is testing whether a digital avatar coach can help reduce anxiety and improve quality of life for cancer patients undergoing outpatient stem cell transplants. Researchers will compare the avatar-based support program against usual care for 90 patients. The goal is to h…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Victor Wang • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Yoga tailored for cancer patients across three nations
Symptom relief Recruiting nowThis study aims to develop and test a yoga therapy program designed to be culturally sensitive for cancer patients undergoing stem cell transplants. The program will be offered to 60 patients in the United States, India, and Tanzania to see if it helps reduce depression and stres…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 20, 2026 14:48 UTC
-
Doctors track diet and body changes after Life-Saving transplants
Knowledge-focused Recruiting nowThis study aims to understand how nutrition affects recovery for people who have had a stem cell transplant. Researchers will follow 200 patients for six months, tracking their food intake, body composition, and blood markers. The goal is to learn how diet and weight changes rela…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Massive study launches to track heart risks for 10,000 stem cell transplant patients
Knowledge-focused Recruiting nowThis study aims to understand the long-term heart health risks for people who have received a stem cell transplant. Researchers will follow 10,000 transplant patients from multiple hospitals, collecting detailed information about their health and any heart-related problems that o…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
New blood test could spot hidden infections in vulnerable transplant patients
Knowledge-focused Recruiting nowThis study is testing whether a new type of blood analysis can detect signs of infections in people receiving a stem cell transplant. Researchers will collect blood samples from 30 participants before and for six months after their transplant to look for bacteria, viruses, or fun…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Helping young patients voice their wishes before risky transplants
Knowledge-focused Recruiting nowThis study is exploring whether structured conversations about future care preferences are helpful and acceptable for young adults (ages 18-39) undergoing stem cell transplants and their caregivers. Participants will have three guided discussions over several weeks to talk about …
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC
-
Tracking the Decades-Long journey after a Life-Saving transplant
Knowledge-focused Recruiting nowThis study aims to understand the long-term health of people who have received a stem cell transplant from a relative. Researchers will follow 2000 transplant recipients and their donors for many years, collecting health data and samples to learn about late complications like new…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:25 UTC